<DOC>
	<DOCNO>NCT02598999</DOCNO>
	<brief_summary>This Phase 1 , randomize , double-blind , placebo-controlled study evaluate safety , tolerability pharmacokinetics single ascend dos ( SAD ) multiple ascend dos ( MAD ) Hypothiocyanite ( OSCN- ) , bovine lactoferrin ( bLF ) combination ( ALX-009 ) healthy male volunteer patient suffer cystic fibrosis .</brief_summary>
	<brief_title>First-in-man Dose Escalation Study ALX-009 Its Components Healthy Men Cystic Fibrosis Suffering Patients</brief_title>
	<detailed_description>Part I : SAD OSCN- bLF healthy male volunteer ( cohort 1 3 ) - Part II : SAD MAD ALX-009 healthy male volunteer ( cohort 4 5 ) - Part III : SAD MAD ALX-009 patient suffer cystic fibrosis ( cohort 6 )</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Hypothiocyanite ion</mesh_term>
	<criteria>Healthy male subject ( Parts I II ) patient suffer cystic fibrosis ( Part III ) , age 18 50 year inclusive Subject 's Body Mass Index 18 30 kg/mÂ² Subject normal blood pressure , heart rate , ECG record laboratory parameter screen visit Subject give write informed consent prior selection Subject cover Health Insurance System and/ compliance recommendation National Law force relate biomedical research Specific Inclusion Criteria Part III : Females childbearing potential : commitment consistently correctly use acceptable method birth control duration trial 4 month last study drug administration / Female nonchildbearing potential : either surgically sterilize least 1 year postmenopausal Subject stable state ( exacerbation 1 month prescription antibiotic intravenous route ) Presence cardiovascular , pulmonary , gastrointestinal , hepatic , renal , metabolic , haematological , neurologic , psychiatric , systemic infectious disease Frequent headaches and/or migraine , recurrent nausea and/or vomit Symptomatic hypotension Blood donation ( include frame clinical trial ) within 2 month administration General anaesthesia within 3 month administration Presence history drug hypersensitivity , allergic disease Medical history reaction cow 's milk protein Subject contact case emergency History presence drug alcohol abuse Positive Hepatitis B surface ( HBs ) antigen anti Hepatitis C virus ( HCV ) antibody , positive result Human Immunodeficiency Virus ( HIV ) 1 2 test Subject , judgement Investigator , likely noncompliant uncooperative study , unable cooperate language problem , poor mental development . Specific noninclusion criterion part III : Exacerbation last month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>